ONCR

Oncorus Stock Price

13.50
-0.66 (-4.66%)
Upgrade to Real-Time
Regular Market
13.50

Low
11.50

52 Week Range

High
37.8603

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Oncorus Inc ONCR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.66 -4.66% 13.50 14:25:07
Open Price Low Price High Price Close Price Prev Close
14.20 13.00 14.25 14.16
Bid Price Ask Price Spread News
13.40 13.54 0.14 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,324 173,788 $ 13.57 $ 2,357,764 113,185 11.50 - 37.8603
Last Trade Time Type Quantity Stock Price Currency
14:28:09 5 $ 13.53 USD

Oncorus Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 305.32M 22.62M 14.90M $ - $ - -3.35 -7.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 10.34M 1.80%

more financials information »

Oncorus News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ONCR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.0314.6313.0013.94113,801-0.53-3.78%
1 Month15.7816.3411.5013.69194,832-2.28-14.45%
3 Months26.0926.76611.5016.02188,645-12.59-48.26%
6 Months17.2937.860311.5020.20139,656-3.79-21.92%
1 Year15.5037.860311.5019.76146,241-2.00-12.9%
3 Years15.5037.860311.5019.76146,241-2.00-12.9%
5 Years15.5037.860311.5019.76146,241-2.00-12.9%

Oncorus Description

Oncorus Inc is a clinical stage biopharmaceutical company focused on developing viral immunotherapies to transform outcomes for cancer patients. The company is in the process of developing intratumorally and intravenously administered product candidates designed to selectively attack and kill tumor cells and stimulate multiple arms of the immune system against tumors.


Your Recent History
NASDAQ
ONCR
Oncorus
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.